Vertex Pharmaceuticals, Inc. (VRTX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Vertex Pharmaceuticals, Inc. (VRTX)
Go deeper and ask any question about VRTX
Company Performance
Current Price
as of Sep 13, 2024$485.37
P/E Ratio
N/A
Market Cap
$125.28B
Description
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Metrics
Overview
- HQBoston, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerVRTX
- Price$485.37+1.40%
Trading Information
- Market Cap$125.28B
- Float99.74%
- Average Daily Volume (1m)978,941
- Average Daily Volume (3m)1,153,305
- EPS-$1.89
Company
- Revenue$10.32B
- Rev Growth (1yr)6.02%
- Net Income-$3.59B
- Gross Margin85.88%
- EBITDA Margin-131.75%
- EBITDA-$3.47B
- EV$116.12B
- EV/Revenue11.25
- P/EN/A
- P/S12.14